business news in context, analysis with attitude

The Food Marketing Institute (FMI) currently is running a quick poll on its website, asking people to address the issue of reimportation of less expensive prescription drugs.

The question:

If the government allows it, would you buy or sell pharmaceutical products re-imported from other countries?

The results are curious (though it has to be kept in mind that this is an unscientific survey because anyone can answer and there are no controls or restrictions on respondents).

Predictably, a majority of respondents – almost 69 percent – said that they would be willing to engage in reimportation, but only through a reputable drug wholesaler.

Slightly more than 28 percent of respondents said that even if the government allowed it, they would be unwilling to reimport pharmaceuticals from abroad – a position, quite frankly, for which MNB would love to hear the rationale.

Just a small cadre of people – about three percent – seem sufficiently fed up with the costs of prescription medicines in the US that they are willing to bring in medicines from other countries “however they can source the product.” Which is a position about which MNB is even more incredulous, since it seems to us that low prices may not and ought not be the final arbiter about which medicine to buy.
KC's View:
We’re not sure that FMI is looking at this information as a barometer of how it should position itself in the debate over reimportation…but the results certainly will be of interest to the folks down in DC.

Make yourself heard on the issue. Go to: